Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females

NCT03615534 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

161

Enrollment

OTHER

Sponsor class

Conditions

Atherogenic Dyslipidemia
Obesity Associated Disorder

Interventions

OTHER: Therapeutic Lifestyle Changes
OTHER: Placebo
DRUG: Fenofibrate
DIETARY_SUPPLEMENT: Wax Matrix Extended Release Niacin (WMER Niacin)

Sponsor

Lewai Sharki Abdulaziz, MSc PhD

Collaborators

[object Object]